**Core Concept**
The patient in question has a 45-year-old lady with Dysfunctional Uterine Bleeding (DUB) and an 8 mm thick endometrial echo, which suggests endometrial hyperplasia or carcinoma. The primary concern is to rule out malignancy and manage her bleeding.

**Why the Correct Answer is Right**
Given the patient's age and symptoms, a thorough evaluation is necessary. The American College of Obstetricians and Gynecologists (ACOG) recommends endometrial sampling for women with postmenopausal bleeding or an endometrial thickness ≥ 4 mm, but in this case, the patient is premenopausal with an 8 mm thick endometrium. Endometrial sampling is indicated to rule out malignancy. This is done through procedures like endometrial biopsy or dilatation and curettage (D&C).

**Why Each Wrong Option is Incorrect**
**Option A:** A trial of hormonal management may be considered in DUB, but it is not the primary approach when there is a suspicion of malignancy.
**Option B:** An ultrasound is already performed, and while it's useful for assessing endometrial thickness, it's not a definitive diagnostic tool for endometrial cancer.
**Option C:** Hysterectomy is a definitive treatment for DUB but is not the first line of management when there's a suspicion of malignancy.

**Clinical Pearl / High-Yield Fact**
Endometrial sampling is essential in premenopausal women with an endometrial thickness ≥ 4 mm to rule out malignancy. The American College of Obstetricians and Gynecologists recommends this approach to avoid missing cancer.

**Correct Answer:** C. Hysterectomy is a definitive treatment for DUB but is not the first line of management when there's a suspicion of malignancy.